Traditional Chinese medicinal composition for treating spleen and kidney yang deficiency and cold turbidity invading type PCI (Percutaneous Coronary Intervention) postoperative contrast medium related renal function impairment

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicinal composition for treating spleen and kidney yang deficiency and cold turbidity invading type PCI (Percutaneous Coronary Intervention) postoperative contrast medium related renal function impairment. The traditional Chinese medicine is prepared from the following traditional Chinese medicinal materials in parts by weight: 5 to 13 parts of pistachio, 5 to 13 parts of white beans, 5 to 13 parts of black soybean, 4 to 8 parts of alpiniaformosanak.sebum, 4 to 8 parts of illicium verum, 4 to 8 parts of tofieldia divergens, 4 to 8 parts of eriobotrya japonica and 4 to 8 parts of licorice root; the medicinal materials are combined to jointly realize the efficacy of tonifying spleen and kidney, and dissipating dampness and descending turbidity; by focusing on the pathogenesis of the PCI postoperative contrast medium related renal function impairment (the spleen and kidney yang deficiency and cold turbidity invading type), the levels of serum creatinine, urine beta 2 microglobulin and cystatin C of patients with the PCI postoperative contrast medium related renal function impairment can be remarkably reduced, so that the kidney is protected, renal functions are improved, and an obvious clinical curative effect is realized; the traditional Chinese medicinal composition is worthy of being popularized and applied.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating contrast agent-related renal function injury after PCI of spleen-kidney yang deficiency and cold-turbid ascending offense type. Background technique [0002] At present, the preferred, safest and most effective method for the treatment of acute myocardial infarction is direct coronary intervention (PCI), because the coronary patency rate is significantly higher than that of other treatments, such as thrombolysis or bypass therapy. Therefore, the number of PCI cases in my country has shown a rapid growth trend in recent years. In the past five years, the annual growth rate has been about 30%. According to incomplete statistics, in 2010, 148,430 PCI cases were completed in hospitals in 1,078 provinces (autonomous regions, municipalities). [0003] With the widespread development of coronary interventional surgery...

AI Technical Summary

Problems solved by technology

RCIN has gradually become a big problem for cardiovascular interventional doctors, because it not only increases the length of hospital stay and medical expenses, but also has a very unfavorable prognosis for patients undergoing intervention

At present, there is no Chinese medicine dedicated to contrast agent-related renal function injury after PCI.